Has Reenal Patel received payments from drug or device companies?

Yes. Drug and device makers reported $43,511 in general payments to Reenal Patel across 620 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Reenal Patel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Reenal Patel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Reenal Patel

Allergy & Immunology · Long Island City, NYNPI 1427218775

Payments from drug & device makers

$43,511in general payments, 2019–2025

Across 620 payments — averaging $70.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$16K
Sanofi$13K
Kaleo, Inc.$4K
GSK$2K
AstraZeneca$2K
Optinose US, Inc.$943
plus $5K from 37 others

What the payments were for

Speaking & faculty fees$28,00964%
Travel & lodging$1,2333%
Food & beverage$13,98232%
Education$2881%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	54	$15,714
Sanofi	86	$13,255
Kaleo, Inc.	56	$4,362
GSK	120	$2,292
AstraZeneca	56	$1,544
Optinose US, Inc.	35	$943
Abbott	8	$770
Novartis	34	$650
Pfizer	28	$491
Abiomed	8	$431
Amgen	16	$371
Incyte Corporation	19	$360
Alk-abello, Inc	10	$212
Biocryst US Sales Co., LLC	8	$178
ARS Pharmaceuticals Operations, Inc.	10	$174
LEO Pharma Inc.	8	$158
Boehringer Ingelheim	9	$150
AbbVie	8	$149
Sanofi-aventis U.S. LLC	3	$138
CSL Behring	4	$120
Bristol Myers Squibb	1	$100
Johnson & Johnson	1	$87
Cvrx, Inc.	2	$86
Genentech USA, Inc.	4	$81
Encore Dermatology Inc.	4	$77
Takeda Pharmaceuticals U.S.A., Inc.	2	$74
Lilly USA, LLC	3	$68
Pharming Healthcare, Inc.	2	$52
Blueprint Medicines Corporation	1	$51
Portola Pharmaceuticals, LLC	3	$41
Galderma Laboratories, L.p.	2	$39
Aimmune Therapeutics, Inc.	2	$39
Teva Pharmaceuticals USA, Inc.	2	$37
Phadia US Inc.	2	$34
Dermavant Sciences, Inc.	1	$26
Grifols USA, LLC	1	$25
Merck	1	$24
Mylan Specialty L.p.	1	$22
Inari Medical, Inc.	1	$20
Medtronic	1	$20
Hikma Pharmaceuticals USA	1	$17
Eyevance Pharmaceuticals LLC	1	$17
Lexicon Pharmaceuticals, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$26,899
AUVI-Q$3,175
TRICLIP$627
BREZTRI$375
Xhance$337
Impella$133
BREZTRI AEROSPHERE$124
NUCALA$108
ZEPOSIA$100

How this compares

$43,511 in reported general payments places this provider in the 80th percentile of 320 allergy & immunology providers in New York.

See all allergy & immunology providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	22	$322
Fluticasone Propionate	16	$132

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Long Island City

Peter DeaneRochester$3.7M
Syed MustafaRochester$3.6M
Golda HudesBronx$2.4M
Arye RubinsteinBronx$1.1M
Ujwala KazaNew York$1.1M
Robert SporterNew York$980K
Mili ShumWest Harrison$924K
Paula BusseNew York$821K
Gregory PuglisiPlainview$813K
Stanley GoldsteinRockville Centre$653K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →